Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 16151-16200 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03787355
Clinical Evaluation of Vertical Inter-implant Papilla Height in Platform Matched Implants in Comparison to Morse Connection Abutments
NA
Active, not recruiting
30 participants
Started: Feb 17, 2019 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT03698019
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma
PHASE2
Active, not recruiting
313 participants
Started: Feb 15, 2019 · Completed: Oct 31, 2025
4 conditions
1 sponsor
820 locations
NCT03522025
GMK-UNI Anatomical UKA: Fixation of Cemented vs Cementless Designs
NA
Active, not recruiting
70 participants
Started: Feb 15, 2019 · Completed: Dec 1, 2026
1 condition
1 sponsor
5 locations
NCT03413384
To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia
PHASE2
Active, not recruiting
100 participants
Started: Feb 15, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
6 locations
NCT03672864
Parent Therapist Partnership to Provide Early, Intensive Exercise in Perinatal Stroke
NA
Active, not recruiting
18 participants
Started: Feb 15, 2019 · Completed: Dec 31, 2026
1 condition
2 sponsors
3 locations
NCT03800823
Overweight and Obesity in Preschoolers
NA
Active, not recruiting
300 participants
Started: Feb 15, 2019 · Completed: Dec 31, 2025
2 conditions
3 sponsors
3 locations
NCT03759379
HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
PHASE3
Active, not recruiting
164 participants
Started: Feb 14, 2019 · Completed: Oct 29, 2025
2 conditions
1 sponsor
53 locations
NCT03624543
CFI-400945 in Patients With Advanced/Metastatic Breast Cancer
PHASE2
Active, not recruiting
51 participants
Started: Feb 14, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
6 locations
NCT03765879
Brain Mechanisms of Video-Guided Acupuncture Imagery Treatment on Chronic Low Back Pain
NA
Active, not recruiting
80 participants
Started: Feb 14, 2019 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT03822572
ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer
NA
Active, not recruiting
92 participants
Started: Feb 14, 2019 · Completed: Jan 31, 2028
1 condition
2 sponsors
8 locations
NCT04029181
ImmunoPET With an Anti-CD8 Imaging Agent
PHASE1/PHASE2
Active, not recruiting
47 participants
Started: Feb 14, 2019 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT03681535
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
NA
Active, not recruiting
241 participants
Started: Feb 13, 2019 · Completed: Jul 31, 2028
1 condition
1 sponsor
12 locations
NCT03500445
Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
PHASE2
Active, not recruiting
75 participants
Started: Feb 13, 2019 · Completed: Jun 30, 2026
2 conditions
3 sponsors
1 location
NCT06737263
Comparison of BioHPP (High Performance Polymer) - vs Titanium- vs Zirconia Abutments
NA
Active, not recruiting
60 participants
Started: Feb 13, 2019 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT04294264
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
PHASE2
Active, not recruiting
50 participants
Started: Feb 12, 2019 · Completed: Mar 27, 2026
6 conditions
2 sponsors
6 locations
NCT03701282
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia
PHASE3
Active, not recruiting
720 participants
Started: Feb 12, 2019 · Completed: May 7, 2028
2 conditions
1 sponsor
870 locations
NCT03824275
18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer
PHASE2/PHASE3
Active, not recruiting
129 participants
Started: Feb 12, 2019 · Completed: Dec 31, 2023
1 condition
1 sponsor
1 location
NCT03817320
PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
PHASE1/PHASE2
Active, not recruiting
24 participants
Started: Feb 12, 2019 · Completed: Jun 30, 2025
3 conditions
3 sponsors
18 locations
NCT03778060
Long-Term Transcutaneous Stimulation and Essential Tremor: A PET Study
NA
Active, not recruiting
20 participants
Started: Feb 11, 2019 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT03846167
Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT
N/A
Active, not recruiting
50 participants
Started: Feb 11, 2019 · Completed: Feb 28, 2027
1 condition
1 sponsor
1 location
NCT06126159
MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers
NA
Active, not recruiting
44 participants
Started: Feb 11, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03765983
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
PHASE2
Active, not recruiting
47 participants
Started: Feb 11, 2019 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT03697148
Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer
NA
Active, not recruiting
852 participants
Started: Feb 11, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
44 locations
NCT03697408
Itacitinib + Everolimus in Hodgkin Lymphoma
PHASE1/PHASE2
Active, not recruiting
23 participants
Started: Feb 11, 2019 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT03828994
Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II
NA
Active, not recruiting
150 participants
Started: Feb 10, 2019 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT03793465
Pilot-Tart Cherry, Mitral Transcriptome, and POAF Incidence
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Feb 8, 2019 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT03673501
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
PHASE3
Active, not recruiting
453 participants
Started: Feb 8, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
121 locations
NCT03967938
Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes
PHASE2
Active, not recruiting
540 participants
Started: Feb 7, 2019 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT03782207
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
N/A
Active, not recruiting
2,756 participants
Started: Feb 7, 2019 · Completed: Jul 31, 2026
4 conditions
1 sponsor
258 locations
NCT03694938
Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients
NA
Active, not recruiting
143 participants
Started: Feb 7, 2019 · Completed: Feb 28, 2030
1 condition
1 sponsor
4 locations
NCT04663048
PiXL as a Treatment for Low Grade Myopia
NA
Active, not recruiting
26 participants
Started: Feb 7, 2019 · Completed: Jun 17, 2024
2 conditions
2 sponsors
1 location
NCT03698487
Pharmacist Led Intervention to Improve Medication Use in Older In-patients Living With Frailty: the Drug Burden Index
NA
Active, not recruiting
200 participants
Started: Feb 6, 2019 · Completed: Aug 31, 2024
2 conditions
2 sponsors
1 location
NCT03630328
Angelica Gigas Dietary Supplements and Human Immune Cells
NA
Active, not recruiting
40 participants
Started: Feb 6, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03724058
Fixation and Stability of the Trident® II Clusterhole HA Shells
NA
Active, not recruiting
87 participants
Started: Feb 6, 2019 · Completed: May 11, 2031
1 condition
1 sponsor
1 location
NCT03518736
Does Timing Matter? Supporting Play, Exploration, and Early Developmental Intervention
NA
Active, not recruiting
85 participants
Started: Feb 6, 2019 · Completed: Jul 1, 2025
2 conditions
2 sponsors
2 locations
NCT03330158
Clinical Assessment of a Motorized Spinal Distraction Rod in the Severe to Early Scoliosis Child
NA
Active, not recruiting
5 participants
Started: Feb 5, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03837821
(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer
EARLY_PHASE1
Active, not recruiting
20 participants
Started: Feb 5, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
4 locations
NCT03799939
Chimney Trial of Parastomal Hernia Prevention
NA
Active, not recruiting
141 participants
Started: Feb 5, 2019 · Completed: Jul 31, 2026
3 conditions
1 sponsor
7 locations
NCT03856658
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
PHASE2
Active, not recruiting
14 participants
Started: Feb 5, 2019 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03568422
CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
PHASE1/PHASE2
Active, not recruiting
37 participants
Started: Feb 5, 2019 · Completed: Dec 31, 2025
1 condition
4 sponsors
4 locations
NCT03317392
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis
PHASE1/PHASE2
Active, not recruiting
133 participants
Started: Feb 4, 2019 · Completed: Apr 30, 2026
3 conditions
1 sponsor
22 locations
NCT03519464
Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia
PHASE2
Active, not recruiting
54 participants
Started: Feb 4, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03933722
Caretaker vs. Blood Pressure Monitoring With Invasive Arterial Pressure Monitoring in Patients With Septic Shock
N/A
Active, not recruiting
40 participants
Started: Feb 4, 2019 · Completed: Feb 5, 2024
1 condition
1 sponsor
1 location
NCT03598998
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
PHASE1/PHASE2
Active, not recruiting
13 participants
Started: Feb 4, 2019 · Completed: Feb 26, 2026
20 conditions
2 sponsors
3 locations
NCT03680586
Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT Lymphoma
EARLY_PHASE1
Active, not recruiting
25 participants
Started: Feb 4, 2019 · Completed: Apr 30, 2028
1 condition
2 sponsors
1 location
NCT03482479
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
PHASE2
Active, not recruiting
36 participants
Started: Feb 4, 2019 · Completed: Dec 31, 2025
7 conditions
1 sponsor
7 locations
NCT04029194
The Causal Effects of Old Age Pensions
NA
Active, not recruiting
1,459 participants
Started: Feb 4, 2019 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03807778
A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer
PHASE1
Active, not recruiting
53 participants
Started: Feb 4, 2019 · Completed: Sep 30, 2026
1 condition
1 sponsor
25 locations
NCT03741374
Minimally-invasive Non-surgical Therapy of Intrabony Defects
NA
Active, not recruiting
66 participants
Started: Feb 1, 2019 · Completed: Dec 31, 2025
1 condition
12 sponsors
9 locations
NCT03696953
The Efficacy of Probiotics to Reduce Antepartum Group B Streptococcus Colonization.
PHASE2
Active, not recruiting
109 participants
Started: Feb 1, 2019 · Completed: Sep 30, 2024
2 conditions
3 sponsors
1 location
Previous
1
More pages
321
322
323
324
325
326
327
More pages
431
Next